Earnings Labs

General Dynamics Corporation (GD)

Q4 2018 Earnings Call· Wed, Jan 30, 2019

$338.14

+7.93%

Key Takeaways · AI generated
AI summary not yet generated for this transcript. Generation in progress for older transcripts; check back soon, or browse the full transcript below.

Same-Day

+0.15%

1 Week

+1.08%

1 Month

-2.43%

vs S&P

-6.85%

Transcript

Operator

Operator

Good morning, and welcome to the General Dynamics' Fourth Quarter and Full Year 2018 Earnings Conference Call. All participants will be in listen-only mode. [Operator Instructions] After today’s presentation, there will be an opportunity to ask questions. [Operator Instructions] Please note this event is being recorded. I would now like to turn the conference over to Howard Rubel, Vice President of Investor Relations. Please go ahead.

Howard Rubel

Analyst · Cowen and Company. Please go ahead

Thank you, Nicole, and good morning, everyone. Welcome to the General Dynamics' fourth quarter and full year 2018 conference call. Any forward-looking statements made today represent our estimates regarding the company’s outlook. These estimates are subject to some risks and uncertainties. Additional information regarding these factors is contained in the company’s 10-K and 10-Q filings. With that, it’s my pleasure to turn the call over to our Chairman and Chief Executive Officer, Phebe Novakovic.

Phebe Novakovic

Analyst · Barclays. Please go ahead

Good morning and thank you Howard. We enjoyed a solid fourth quarter, the results in comparisons with prior period were straightforward for the most part. As a result, I will go through them briefly to leave more time for my thoughts on the business segments, our outlook for 2019 and your questions. I also think you will find the press release and the additional presentation on our website fulsome and helpful. So earlier today, we reported fourth quarter revenue of $10.38 billion, earnings from continuing operations of $909 million and earnings of $3.07 per fully diluted share. This is a significant improvement against the fourth quarter of 2017, which was adversely impacted by a discrete, $119 million increase in the tax provision as a result of a 2017 Tax Cuts and Jobs Act. Even after adjusting for the adverse impact in Q4, 2017. EPF was up $0.07 and earnings from continuing operations were up $154 million. Earnings per share at $3.07 also beat consensus by $0.09. Revenue and operating earnings were largely consistent with consensus. Most of the difference comes from a lower tax provision and a somewhat lower share count. For all-in-all, a solid quarter, with good performance, particularly compared to the year ago quarter as well as the third quarter of 2018. For the year, we had fully diluted earnings per share from continuing operations of $11.22. This is also $0.09 above consensus. Revenue was $36.2 billion was up over 2017 by $5.2 billion. On an organic basics, excluding CSRA, revenue was up $1.5 billion. Revenue was up across each of our reporting segments. Operating earnings of $4.5 billion were up $221 million or 5.2% over 2017. Earnings from continuing operations were up $446 million or 15.3% over 2017. Importantly, earnings per share from continuing operations were $166…

Jason Aiken

Analyst · Barclays. Please go ahead

On that note, let me make some comments about GDIT and Mission System’s performance in 2018. We originally guided to full year revenue for the former IS&T business group between $9.3 billion and $9.4 billion, and operating earnings of approximately one billion 30 million. If we look at how Mission Systems and GDIT excluding CSRA did for the year, they combined for $9.325 billion in sales, so in line with our expectations and that includes an organic growth rate of 4.3% for GDIT notwithstanding the impact of several divestitures during the year. From an operating earnings perspective, they were actually closer to $1.50 billion on a combined basis, so somewhat better than we had expected. So all-in-all a solid year for both businesses. As I alluded to, we also completed several portfolios shaping our activities in our GDIT segment during the year. These included the sale of a commercial health products business, CSRAs SETA business, and our public-facing call centers. These divestitures of more than $1 billion of annualized sales enhance the group's focus on high-end solutions and high-value added customer needs.

Phebe Novakovic

Analyst · Barclays. Please go ahead

So let’s first address information technology. Information technology enjoyed revenue in the quarter of $2.38 billion and operating earnings of $194 million with an operating margin of 8.1%. Since the numbers for the fourth quarter of 2017 did not include CSRA, comparison to the year ago quarter are not particularly meaningful. However, sequentially revenue is up $75 million, operating earnings up $37 million and operating margin up 130 basis points, evidence of our continuing ability to extract cost synergies here. For the year, revenue was $8.27 billion and operating earnings were $608 million with a 7.4% margin, once again annual comparisons do not offer meaningful perspective since the prior year did not include CSRA. Next, Mission Systems. Revenue in the quarter was essentially flat against the year ago quarter, while operating earnings of $181 million were $6 million lower than the fourth quarter last year on a 40 basis point decrement in operating margin. For the year, revenue of $4.73 billion was up $245 million or 5.5%. Operating earnings of $659 million were up $21 million or 3.3% due to a 30 basis point decline in operating margin driven in part by mix. Book-to-bill for the year was somewhat above 1 times till the end of the year with the modestly higher backlog at 5.3 billion. So on this call last year on a company wide basis, our forecast for 2018 was to expect revenue of 32.35 billion to 32.45 billion. Operating earnings of 4.25 billion and an operating margin of 13.1%. And as you know, we wound up with $36.2 billion on an organic basis, but on an organic basis, revenue was up $1.5 billion, $500 million more than forecast. At the EPS line, we forecasted $10.90 to $11 and came in at $11.22 including, the transaction costs related…

Phebe Novakovic

Analyst · Barclays. Please go ahead

Thank you, Phebe. Our net interest expense in the quarter was $112 million bringing the interest expense for the year to $356 million. That compares to $27 million and $103 million in the comparable periods of 2017. The increase in 2018 is due to the roughly $10 billion of debt we issued to finance the acquisition of CSRA. We repaid approximately $1.7 billion of this debt during the year, and will continue to prioritize paying down debt consistent with our Mid-A credit rating. We ended the year with $850 million of commercial paper outstanding, and our next scheduled fixed debt maturity is in the second quarter of 2020. For 2019, we expect interest expense to be approximately $430 million reflecting a full year of the notes issued in 2018. Our effective tax rate was 19.7% for the quarter and 17.8% for the year in line with our previous guidance. Looking ahead to 2019, we expect a full year effective tax rate in the low 18% range, between 18% and 18.5%. This is slightly higher than 2018, but recall in 2018, we took advantage of a onetime benefit provided by tax reform, and made a $255 million discretionary pension contribution, which lowered the tax rate by approximately 75 basis points. Looking at capital deployment, we paid $274 million in dividends in the fourth quarter bringing the full year to $1.1 billion. We also took advantage of the market decline in December, by purchasing our shares to a greater degree than planned. In the quarter, we purchased 7.6 million shares of our stock for $1.3 billion bringing the full year to 10.1 million shares for $1.8 billion. Looking ahead, while debt repayment will continue to be a priority as I mentioned, we continue to have the flexibility to adjust our capital deployment…

Howard Rubel

Analyst · Cowen and Company. Please go ahead

Thanks Jason. As a reminder, we asked participants ask one question and one follow up so that everyone has a chance to participate. Nicole, could you please remind participants how to enter the queue.

Operator

Operator

Thank you. [Operator Instructions] Our first question comes from David Strauss of Barclays. Please go ahead.

David Strauss

Analyst · Barclays. Please go ahead

Thanks. Good morning.

Phebe Novakovic

Analyst · Barclays. Please go ahead

Morning David.

David Strauss

Analyst · Barclays. Please go ahead

Phebe, can you, can you give us a little bit more detail on the on the IT guide. I understand, with the divestitures, you know that’s a headwind on the top line, but you have one additional quarter of CSRA and in terms of the margin guide, I would have thought, we would have seen some margin improvement here given what’s going on with intangible, amortization and additional synergies? Thanks.

Phebe Novakovic

Analyst · Barclays. Please go ahead

So let’s talk a little bit about this business. In a growing environment last year, they had a one-to-one book-to-bill. They also have a 75% win rate and a $26 billion pipeline. This management team is performing the cost synergies beautifully, and frankly is a bit of ahead of schedule. By the way, this is a very energetic, innovative, management team that is really making GDIT into a workplace of preference. And in this market, people are absolutely critical and important across the board. But, people here truly matter. I might also add the cash performance on this business is outstanding. Last year, they generated over 100% percent of net income in cash and we’ll continue that this year and for the years to come. So, so what we see this year? Despite that large backlog -- despite the large win rate and book-to-bill is this is simply a question of timing, when the contracts move from the backlog into sales. And you’ll see the growth rate increase in the third quarter, fourth quarter and then significantly next year. This is just a question of the timing of several hundred contracts moving from backlog, into our sale. That also is impacting the margin rate. So I’m very confident in the ability of this business to perform than outperform their cost synergy. They are growing great cash performance, so in the instance right now, it’s simply a question of timing.

Jason Aiken

Analyst · Barclays. Please go ahead

And Dave, if you want me to, I’ll add a little bit of additional color around your influence on margin rates. If you look at the 7.4% margin rate that we reported for the year for the group. If you normalize that for the amortization burden that came with the CSRA acquisition and take that out, you actually end up with a margin rate of 9.6% for the year. So that’s a couple of hundred basis points better than we reported and about 110 basis points better than the year ago 2017 full year rate. That’s really driven by the CSRA contribution from an operations perspective if you will. So they actually contributed approximately 10.9% incremental margins on the core business, excluding at amortization benefit. Now when you look ahead to next year, when you take the puts and takes on the revenue side between the additional quarter of CSRA volume offset by the divestitures were nominally up, let’s just call it notionally flat, but nominally up. So even though we do have because of the accelerating amortization schedule that we have for this business, even though we do have a somewhat declining quarterly amortization burden, the fact that we have four full quarters of amortization versus a flattish to slightly nose knows up total top line is actually perhaps counter intuitively a little bit of a margin drag for next year. It will start to accelerate for the following year once we have a full up year-on-year comparison. So if you think about amortization, is really call it a 20 – I’ll call the 20ish basis point drag. The other part of it is -- is we do have synergies as Phebe mentioned that are accelerating, so I’d call that maybe an 80 basis point to 90 basis point assist, as we go forward and we’ll continue to accelerate after that. And then from a mix perspective issue alluded to, when we talked about this for some time after the acquisition, we did forecast, call it 100 basis point to 150 basis point contraction overall in the incremental CSRA margins over the next 3, 4 years. So call it 50 basis points or so from that. So, if you take the 20ish basis points on amortization, if you call it 50 basis points on mix offset by a positive 80 basis point to 90 basis point improvement from synergies, you get call it 10 basis point to 20 basis point that improvement for the year, and we would see it accelerating after that. So, hopefully that color is helpful.

Operator

Operator

Our next question comes from Robert Stallard of Vertical Research. Please go ahead.

Robert Stallard

Analyst · Vertical Research. Please go ahead

Thanks so much. Good morning.

Phebe Novakovic

Analyst · Vertical Research. Please go ahead

Good morning.

Robert Stallard

Analyst · Vertical Research. Please go ahead

Phebe, I was wondering if you could comment on the Aerospace demand environment. This was the basing concerns out there about the global economy and whether that's had any flow-through to customer demand for your product in the last three months. Thank you.

Phebe Novakovic

Analyst · Vertical Research. Please go ahead

So I may pass that for you. Our North American demand is robust and growing. Western Europe is been -- it’s been very active for us translating into addition to orders as well as considerable activity in our pipeline. I would say some of the emerging markets are a little bit more cautious. They tend to be focused on the 650 and on new products, but overall very very nice, very nice demand and interest in North America and Western Europe.

Operator

Operator

Our next question comes from Ronald Epstein of Bank of America Merrill Lynch. Please go ahead.

Ronald Epstein

Analyst · Bank of America Merrill Lynch. Please go ahead

Yes. Good morning. Another maybe follow up question quickly on Aerospace. When you compare this release to your last release last quarter, and you’ll get the estimated potential contract value, it went up by almost a billion. Can you help us understand what that means and what gets thrown in that pile and why it would go up by a billion?

Phebe Novakovic

Analyst · Bank of America Merrill Lynch. Please go ahead

Well let me ask Jason, to give you a little color on that.

Jason Aiken

Analyst · Bank of America Merrill Lynch. Please go ahead

So Ron, one of the last comments that I made was around this area and it typically in the estimated potential contract value bucket for the defense businesses. That’s clearly contract options and IDIQ potential value. For Aerospace, it holds a number of items to include options for aircraft as well as longer term arrangements that we have with individual customers. So where deliveries may be further out in the delivery queue and spread out in the backlog. So as I mentioned, we did have in the fourth quarter, a fairly large contract signed up with an existing commercial customer it was valued at just over a billion dollars. It’s a multi aircraft, multi-year arrangement that spans out over several years that did not go into the firm backlog because that order is actually subject to that customer’s board approval coming up later this quarter. So we expect that to happen this quarter, and we’ll move into the firm backlog, and be counted as traditional orders at the time. But given the maturity of that and where it was in the quarter, that’s why we put it in the as we typically are conservative on these notions, we put it in the potential contract value bucket versus in the firm backlog till we till we get to that firm order.

Ronald Epstein

Analyst · Bank of America Merrill Lynch. Please go ahead

Okay great. And if I may do one follow up for Phebe. When you think about the current political environment and what that means for defense spending, and then how do you pass through that? It seems like there’s just a lot of uncertainty and volatility going on. So you know in your experience, how do you think about it?

Phebe Novakovic

Analyst · Bank of America Merrill Lynch. Please go ahead

Well, some of the political contretemps haven’t necessarily affected their defense spending if and in fact, defense spending has been increasing in this environment. So we are quite comfortable that we’re going to see through our at least initial planning horizon, very nice funding for all of our key programs. So I haven’t seen too much perturbation as a result of some of the extant issues with respect to the overall budget impacting defense.

Operator

Operator

Our next question comes from Robert Spingarn of Credit Suisse. Please go ahead.

Robert Spingarn

Analyst · Credit Suisse. Please go ahead

Good morning Phebe or Jason. I wanted to see if we could dig a little bit more into the margin pressure you expect in the front end of 2019 and what you saw on the back end of 2018. How do we pass the pressure between the completion issues Phebe that you cited at Jet Aviation, just the general learning curve and conversions you’re doing on five hundreds and six hundreds, and specifically NORDAM. Where does NORDAM factor into this, and how quickly do you get a lift as that problem diminishes?

Phebe Novakovic

Analyst · Credit Suisse. Please go ahead

So let’s take it in reverse order. We’ve got on Nacelle line well under control, the cost performance has been quite good. And as I mentioned in my remarks, we’ve had to spool back up the supply chain. That is the pacing item with respect to our timing of our deliveries, but the supply chain is doing well and it’s just going to take them a while to begin to have the capacity and the throughput and product to feed our demand. So I will see a little bit of slowness on that on the delivery in the south. But as we get into the second half, that will have completely resolved and we will be in full rate production throughout the supply chain. So we’re quite pleased with that. The margin compression it has been something we’ve been talking to you all for some time about. As you all know, the first lot of airplanes in this case, we’re talking about the G500 carried very little margin. Those airplanes will ramp up, continue to ramp up that production and first quarter, second quarter as we move from that initial lot to carry those lower margins and you’ll see some, we will see some margin expansion on that line. The 600 will come in at slightly higher entry margins, simply because of the disproportionate amount of test cost and on deep costs borne by the 500. And then we’ll nicely come down its learning curve. So those are some of the issues that we would see with respect to the margins. The completion business, the jet we had a problem this year on really on the operating side. We have fixed that, and going forward, we’re comfortable that they will do better this year.

Robert Spingarn

Analyst · Credit Suisse. Please go ahead

So Jet is not really not part of the 2019 pressure?

Phebe Novakovic

Analyst · Credit Suisse. Please go ahead

No, [Indiscernible]. No they’re not. They will do better this year because of the affirmative and proactive steps they took in 2018. So you think -- much about mix.

Robert Spingarn

Analyst · Credit Suisse. Please go ahead

Once you’re through this year, do you recover to the old margins at Aerospace?

Phebe Novakovic

Analyst · Credit Suisse. Please go ahead

We’ll have, as we continue to come down on a learning curve. We finish up a lot of the 500, the first lot of 500 airplanes, the first flight of 600 airplanes; you can expect us to come quickly down our learning curve. And I mentioned in my remarks, we’ll see some earnings and margin expansion in 2020 and then really quite nice expansion and considerable earnings growth thereafter, as we have completed all of those two transitions. So I’m not going to predict exactly where we end up on new airplanes with respect to terminal margins here. But, you should expect us to continue the strong operating performance you have seen from us. We know how to build these airplanes, low cost high, quality provider. We're good at that.

Operator

Operator

Our next question comes from Myles Walton of UBS. Please go ahead.

Myles Walton

Analyst · UBS. Please go ahead

Thanks. Good morning. I was hoping we could get some color on that Canadian Lab program that was weighing on the conversion this year, and you probably had maybe a billion of revenue on that program. I’m curious, are you getting, are you getting any cash on the program an ongoing basis, and what would the conversion have looked like if not for the progress delays?

Phebe Novakovic

Analyst · UBS. Please go ahead

So let me give you some context here Myles. This is a valid contract that all parties to that contract have repeatedly and recently attested to their commitment to honor that contract. The Canadian government fully understands the importance of our high end manufacturing and engineering talent in London, Ontario and the robust supply chain that we have throughout the country. Our payment issue got caught up in a larger international political issue diplomatic issue. That's why we got some payment last year. Those diplomatic contretemps affected, that slowed the payment that they would otherwise have anticipated. So that will resolve. It’s a timing issue, and we’re quite comfortable and quite confident that that will resolve just at a slower rate than we had anticipated.

Myles Walton

Analyst · UBS. Please go ahead

In just about a breadbox around it, Jason would you have been above 90% adjusted for pension conversion if you get this?

Jason Aiken

Analyst · UBS. Please go ahead

That’s correct. We would have then call it net 95%, 200% range we’ve been targeting.

Operator

Operator

Our next question comes from George Shapiro of Shapiro Research. Please go ahead.

George Shapiro

Analyst · Shapiro Research. Please go ahead

Yes. Phebe, I wanted to ask on Gulfstream. I thought, you’d implied in the third quarter that the book-to-bill would get close to one. So if you just comment on what might have happened, so since we wound up somewhat less than that?

Phebe Novakovic

Analyst · Shapiro Research. Please go ahead

I believe George what I said was that the orders would be better in the fourth quarter than they were in the third quarter. In fact, they were. And you know the book-to-bill was nice particularly I think. But when you look at the addition of delivery, a considerable number of additional deliveries that we added in the fourth quarter. But you know the quarterly book-to-bill, if you go back and looked at Gulfstream, Aerospace tends to have some lumpiness that we had very nice order activity last year, and the fourth quarter was about what we anticipated the orders would be better than the third quarter. And I would also point out that we’ve got a, Jason talked about at some length, a billion dollar order with a customer that once it gets cleared by its board, moves into backlog. So I consider that, we had a good -- we had a good order quarter.

George Shapiro

Analyst · Shapiro Research. Please go ahead

Okay. And then just could you quantify at all how much the incremental costs at NORDAM may have impacted the margin in the quarter?

Phebe Novakovic

Analyst · Shapiro Research. Please go ahead

Now that’s almost impossible to deconstruct. I’m very pleased with how quickly we’ve got some really good operators in Tulsa. And I’m really pleased at how quickly they were able to stabilize the line. We’ve got good performance, good cost control. And frankly, we’ve got now aligned supply chain. Though, I don’t know the any particular impact of that in with any specificity.

Operator

Operator

Our next question comes from Carter Copeland of Melius Research. Please go ahead.

Carter Copeland

Analyst · Melius Research. Please go ahead

Hey, good morning all.

Phebe Novakovic

Analyst · Melius Research. Please go ahead

Hi, Carter.

Carter Copeland

Analyst · Melius Research. Please go ahead

Phebe, just given where we are in the life cycle of the 650, I know historically you’ve given us sort of a framework and how you think about products and their lifecycle and we just got the seventh anniversary of entry and a service on the 650. So I think we’ll be halfway through that kind of 15 year life cycle that you usually reference in the next couple of quarters, and I wondered if you could just kind of update us on how you think about the lifecycle of that particular product as we look forward in this year.

Phebe Novakovic

Analyst · Melius Research. Please go ahead

So I am -- as you can well imagine, not about comment on what our thinking is about new product introductions, but you can imagine that our pea-shooter is full, that’s the way you ought to think about it.

Carter Copeland

Analyst · Melius Research. Please go ahead

Okay, then I’ll try another one. Jason, the comment on CapEx, just as we think about cash flow. When -- when do you see the Marine? I’m not – I’m not sure if you can answer this yeah just based on the planning. But, when should we think that the CapEx build in Marine sort of levels off from a longer term standpoint. Is that still a couple of years away?

Jason Aiken

Analyst · Melius Research. Please go ahead

It is, its call it over the next couple of years two, between two and three years and then you’ll see that tail back to a more normal level. So as I mentioned, over the more intermediate planning horizon, we do continue to see that. I think more reliable 90 to 90% to 100% cash conversion rate as a result.

Operator

Operator

Our next question comes from Cai von Rumohr of Cowen and Company. Please go ahead.

Cai von Rumohr

Analyst · Cowen and Company. Please go ahead

Yes thank you very much. So, Phebe, I believe Mark Burns who runs a Gulfstream has said at some point you’ll have a competitor to the global 70 500 in the market. And you obviously have an opportunity back where the 450 was. And, you obviously have probably taken a little bit longer than you expected on certifying the G600. So if we think about R&D, was that high in the fourth quarter -- higher -- high relatively high in the fourth quarter, and you know what, what comment can you give us in terms of what sort of a drag that will be on 2019?

Phebe Novakovic

Analyst · Cowen and Company. Please go ahead

So let me just gently tease you a bit about not trafficking in what I call rumor intelligence or not. So with that cautionary note, our certification has come along quite nicely. As I told you, it’s a little slower than we anticipated. You know this is a -- this is a detailed and appropriately robust process that unfortunately got impacted by the shut down and I apologize for my early optimism, but originally, in plan, our internal plan was first quarter and we think that, that because of that perturbations of the shutdown that’s going to move into the second quarter. Jason will talk about the R&D.

Jason Aiken

Analyst · Cowen and Company. Please go ahead

Yeah. Cai, the R&D for the quarter was essentially flat year-over-year. It was up a little bit sequentially from the third quarter if you go back and look at that data, call it by a roughly $20 million or so. I think for the year we ended up right around 1.5% of sales for total Company-sponsored R&D. So I don’t think high or low in any anomalous way, and I think we expect to see, as we have in the past, a continued steady drip, and Phebe alluded to it on R&D, as we continue to -- the pipeline of new product introductions and technology introductions. So I don’t think anything anomalous up or down.

Cai von Rumohr

Analyst · Cowen and Company. Please go ahead

Got it. Thank you. Just a last quick one. Congratulations on your aggressive share repurchase in the fourth quarter. Should we assume that you carry your comparable opportunistic approach into this year? And would you legally have been able to buy any shares early in this quarter?

Phebe Novakovic

Analyst · Cowen and Company. Please go ahead

You wisely have assumed that we will continue our opportunistic buying. And you -- I think you well know about the mechanism for share buybacks during the blackout. So I think we’ll leave a comment around that later. But we were very active in the fourth quarter, I think that's the way to think about it.

Howard Rubel

Analyst · Cowen and Company. Please go ahead

Operator, we have time for two more questions.

Operator

Operator

Thank you. Our next question comes from Peter Arment of Baird. Please go ahead.

Peter Arment

Analyst · Baird. Please go ahead

Yeah. Thanks. Good morning, Phebe. Phebe, just thinking about some of the good news that’s going on in Marine, and just thinking back to your kind of your longer-term targets there, you’ve had some really nice contract wins since those projections. So is this volume falling outside of that kind of scope for the 2020 targets? Or is this delivering you some additional upside, because it seems like you are tracking ahead of that. Just some additional color there would be great.

Phebe Novakovic

Analyst · Baird. Please go ahead

So the proponents of the growth we are going to see is, is at Electric Boat and submarines. We’ve gotten some nice wins at past. I think they’ve got 11 DDG-51s in their backlog now, and they will continue to turn through those. NASSCO started its first containership Matson about two months early. They’re working on the next oiler, and they’ve got that extraordinarily versatile platform in the ESB. So they have done nicely with slow steady growth, but the real growth driver is Electric Boat. And you see that in two respects. Both on the – we’ve got the Virginia class two-year volume in Block IV, and then Block V is a -- as I noted in my remarks, really a significant upgrade into the performance, and it is a let me just leave it at that. It is -- it will drive additional revenue, incremental revenue. And then the advent of the Columbia, which will begin early construction in next year. So this is a steady growth engine for us as we’ve been saying for some time. I’m very pleased with them.

Operator

Operator

Our next question and our last question comes from Hunter Keay of Wolfe Research. Please go ahead.

Hunter Keay

Analyst · Wolfe Research. Please go ahead

Thank you for squeezing me on. Phebe, just another question on sort of product development. As you think about sort of the long-term and some lessons learned on the G650. You talked a lot about speed before as being an important value proposition to your new customers for these high-end products. Is there any sort of evolving sort of appetite for new capabilities beyond just speed, as you think about product development in the next 5 to 10 years? Is it like runway access, access to remote regions, anything like that? Or is it really just sort of like a speed concept to sort of the next value proposition?

Phebe Novakovic

Analyst · Wolfe Research. Please go ahead

Speed is important, but as you can well imagine, we continue to upgrade and innovate around the avionics, cabin comfort, and the engines, both in fuel efficiency, decibel levels, and -- and look, these airplanes are getting better and better and better across the spectrum. Speed, for us, is an important commodity, because people’s time is precious, so you’re quite right, deposit, but that has been our focus, but it is by no means the single and exclusive focus.

Hunter Keay

Analyst · Wolfe Research. Please go ahead

Thank you.

Howard Rubel

Analyst · Wolfe Research. Please go ahead

Thank you, operator. With that we will end our call. If you -- if anybody has follow-up questions, please don't hesitate to reach out and call me. My number is 703-876-3117. Thank you all again, and you can sign off.

Operator

Operator

The conference is now concluded. Thank you for attending today’s presentation. You may now disconnect.